Howard Fingert

发表

Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics

Arijit Chakravarty, Hua Liu, Jeffrey Ecsedy, 2010, Molecular Cancer Therapeutics.